Codexis (CDXS) Cash from Investing Activities (2010 - 2026)

Codexis' (CDXS) quarterly Cash from Investing Activities came in at -$1.1 million in Q1 2026, down 109.44% year-on-year from $11.8 million in Q1 2025, and down 119.45% quarter-over-quarter from $5.7 million in Q4 2025.

Codexis (CDXS) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Codexis' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 109.44% year-over-year to -$1.1 million in Q1 2026; TTM through Mar 2026 was $10.6 million, a 163.8% increase from a year earlier, with the FY2025 full-year figure at $23.5 million, up 141.25% from the prior year.
  • Cash from Investing Activities eased to -$1.1 million in Q1 2026 per CDXS's latest filing, from $5.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $11.8 million in Q1 2025 and bottomed at -$28.6 million in Q1 2024.
  • The 5-year median for Cash from Investing Activities is -$1.1 million (2026), against an average of -$3.1 million.
  • Across the five-year window, Cash from Investing Activities jumped 3245.45% in 2023 and slumped 1624.19% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at $33000.0 in 2022, then soared by 3245.45% to $1.1 million in 2023, then plunged by 359.33% to -$2.9 million in 2024, then soared by 299.55% to $5.7 million in 2025, then slumped by 119.45% to -$1.1 million in 2026.
  • Per Business Quant, the three latest CDXS Cash from Investing Activities figures stand at -$1.1 million (Q1 2026), $5.7 million (Q4 2025), and $6.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,741.39 Bn 66,741.11 Bn - -
2 Nanobiotix 1,912.31 Bn 1,912.25 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
4 BeOne Medicines 467.15 Bn 462.36 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 123.00 Bn 115.76 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 70.22 Bn 61.47 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.93 Bn 62.93 Bn - -
8 Argenx Se 55.76 Bn 50.57 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.70 Bn 34.69 Bn 959.66 Mn -25.54 Mn
10 Codexis 141.60 Mn 76.46 Mn 13.18 Mn -1.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.11 Mn
Mar 31, 2026 -1.11 Mn
Dec 31, 2025 5.71 Mn
Dec 31, 2025 5.71 Mn
Sep 30, 2025 6.39 Mn
Sep 30, 2025 6.39 Mn
Jun 30, 2025 -367,000.00
Jun 30, 2025 -367,000.00
Mar 31, 2025 11.77 Mn
Mar 31, 2025 11.77 Mn
Dec 31, 2024 -2.86 Mn
Dec 31, 2024 -2.86 Mn
Sep 30, 2024 1.53 Mn
Sep 30, 2024 1.53 Mn
Jun 30, 2024 -27.09 Mn
Jun 30, 2024 -27.09 Mn
Mar 31, 2024 -28.56 Mn
Mar 31, 2024 -28.56 Mn
Dec 31, 2023 1.10 Mn
Dec 31, 2023 1.10 Mn